Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/ROCHE-HOLDING-AG-68997/news/Roche-erhalt-US-Zulassung-fur-Cobas-Diagnostiktest-bei-Follikularem-Lymphom-30796572/?utm_source=whatsapp&utm_medium=social&utm_campaign=share